Who
Uri Geiger
Director
Company insider
Files Form 4 as: Director, Neuropace; Director and 10% owner, STRATA Skin Sciences; Director, Cogentix Medical Inc /de/; Director, EndoChoice Holdings; Director, Ophthalmic Imaging Systems.
In numbers
- Trades disclosed
- 31
- Buys
- 1
- Sells
- 0
- Bought
- $724K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 23 Mar 2011
- Last trade
- 19 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Jun 2026filed 22 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K789 at $15.63 | filing |
| 19 Jun 2026filed 22 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K789 at $15.63 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —5,368 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —2,890 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K913 at $13.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K913 at $13.00 | filing |
| 19 Dec 2025filed 23 Dec 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K715 at $16.59 | filing |
| 19 Sep 2025filed 22 Sep 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,194 at $9.94 | filing |
| 21 Jun 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,140 at $10.41 | filing |
| 6 Jun 2025filed 9 Jun 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,745 at $0.00 | filing |
| 21 Mar 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K987 at $12.02 | filing |
| 21 Dec 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,029 at $11.53 | filing |
| 30 Sep 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,703 at $6.97 | filing |
| 15 Jul 2024filed 17 Jul 2024 | STRATA Skin Sciences | SEC FORM 4 Bought | $724K230,573 at $3.14 | filing |
| 28 Jun 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,570 at $7.56 | filing |
| 7 Jun 2024filed 11 Jun 2024 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,774 at $0.00 | filing |
| 29 Mar 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K899 at $13.20 | filing |
| 29 Dec 2023filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $12K1,151 at $10.31 | filing |
News
No headline names them, or the companies they trade most, lately.